BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1056 related articles for article (PubMed ID: 22201706)

  • 1. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.
    Huclier-Markai S; Alliot C; Varmenot N; Cutler CS; Barbet J
    Curr Top Med Chem; 2012; 12(23):2642-54. PubMed ID: 23339760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein targeting constructs in alpha therapy.
    Olafsen T; Elgqvist J; Wu AM
    Curr Radiopharm; 2011 Jul; 4(3):197-213. PubMed ID: 22201709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Alpha Therapy: Current Clinical Applications.
    Guerra Liberal FDC; O'Sullivan JM; McMahon SJ; Prise KM
    Cancer Biother Radiopharm; 2020 Aug; 35(6):404-417. PubMed ID: 32552031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-particle microdosimetry.
    Chouin N; Bardies M
    Curr Radiopharm; 2011 Jul; 4(3):266-80. PubMed ID: 22201713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Targeted Alpha Particle Therapy for Solid Tumors.
    Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
    Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
    Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry in targeted alpha therapy. A systematic review: current findings and what is needed.
    Tronchin S; Forster JC; Hickson K; Bezak E
    Phys Med Biol; 2022 Apr; 67(9):. PubMed ID: 35316802
    [No Abstract]   [Full Text] [Related]  

  • 10. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Lee D; Li M; Bednarz B; Schultz MK
    Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of targeted alpha therapy.
    Kim YS; Brechbiel MW
    Tumour Biol; 2012 Jun; 33(3):573-90. PubMed ID: 22143940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
    Lindegren S; Frost SH
    Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy with α-particle-emitting radionuclides.
    Seidl C
    Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy using alpha emitters.
    Vaidyanathan G; Zalutsky MR
    Phys Med Biol; 1996 Oct; 41(10):1915-31. PubMed ID: 8912371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.
    Sgouros G; Hobbs R; Josefsson A
    Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
    Kennel SJ; Mirzadeh S; Eckelman WC; Waldmann TA; Garmestani K; Yordanov AT; Stabin MG; Brechbiel MW
    Radiat Res; 2002 Jun; 157(6):633-41. PubMed ID: 12005541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-225.
    Castillo Seoane D; de Saint-Hubert M; Crabbe M; Struelens L; Koole M
    Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):265-277. PubMed ID: 32441067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.
    Vaidyanathan G; Zalutsky MR
    Curr Radiopharm; 2011 Oct; 4(4):283-94. PubMed ID: 22202151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.